UK BIOBANK LIMITED

• ◆

  6 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

BDO LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“UK Biobank has committed core funding of £52.0m to cover its core operations until 30 June 2029. The provision of funding beyond 30 June 2027 is subject to a quinquennial review. UK Biobank recognised £7.7m of core funding in 2023-24. UK Biobank has undertaken an assessment (on a reasonable worst-case scenario basis) of its cashflow over the period to 30 September 2026. This analysis shows that under a reasonable worst-case scenario, UK Biobank will nonetheless have sufficient funds to continue to operate for a period not less than 12 months from the date these accounts were signed. Additionally, UK Biobank continues to benefit from funding contributions committed through the philanthropic consortium. These funds are enabling UK Biobank to fulfil its potential and can be applied flexibly to its priorities over the next four years. The Directors have a reasonable expectation that sufficient funding will be available to enable UK Biobank to continue to operate for the foreseeable future, and therefore, the financial statements are prepared under the going concern basis”

Significant events

• “Brain Health Study launched, a first-of-its-kind project to collect brain scans and health data from participants with dementia by 2029.”
• “Received over £16 million in donations from philanthropists Eric Schmidt and Ken Griffin, and £8 million worth of cloud computing storage from Amazon Web Services, all matched by the UK government.”
• “Created an industry-sponsored fund to provide researchers from less wealthy countries free access to data and a high-powered computing data analysis platform.”
• “Made great progress in securing access to participants' primary care data, with NHS England taking responsibility for providing this data to consented studies.”
• “Formed a new 18-member Participant Advisory Group to guide work with their perspectives and lived experience.”
• “Introduced a cloud-based Research Analysis Platform (RAP) as the default way for researchers to access data, with over 8,000 scientists now using it.”
• “Secured funding and commenced construction for a new headquarters in Manchester Science Park, due to open in 2026, which will include a latest-generation robotic freezer.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

11

last 12 months

Capital events

0

last 24 months

Officers appointed

2

last 12 months

Officers resigned

6

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +121%

  £34,535,326 → £76,327,574

• Cash

  +130.7%

  £18,174,057 → £41,926,967

• Net assets

  +1,586.5%

  £2,882,339 → £48,609,701

• Employees

  +23.7%

  228 → 282

• Operating profit

  +1,806.7%

  £2,398,279 → £45,727,362

• Wages

  +24.1%

  £10,169,965 → £12,623,300

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers